Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To survey the grade of gastric MALT lymphoma after eradication of Helicobacter pylori
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Treatment Arm 1 Rabeprazole Sodium |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Rabeprazole Sodium | Drug | The following 3 drugs are taken orally at the same time twice daily for 7 days: rabeprazole sodium 10 mg, amoxicillin hydrate 750 mg, and clarithromycin 200 mg. The dose of clarithromycin may be properly increased as needed, although the upper limit is 400 mg twice daily. If Helicobacter pylori eradication with proton pump inhibitor, amoxicillin, and clarithromycin fails, the following 3 drugs will be taken at the same time twice daily for 7 days as an alternative treatment for adults: rabeprazole sodium 10 mg, amoxicillin hydrate 750 mg, and metronidazole 250 mg. |
| Measure | Description | Time Frame |
|---|---|---|
| Response rate of gastric low-grade MALT lymphoma by eradication of Helicobacter pylori | Every 3 months within the 1st year and every 6 months | |
| Transition rate to secondary therapy for eradication of Helicobacter pylori | Every 6 months within the 1st year and every 12 months as needed |
Not provided
Not provided
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
Hospitals and Clinics in Japan
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Katsuya Sugizaki | Drug Fostering and Evolution Coordination Department, Eisai Co., Ltd. | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nagoya | Aichi-ken | Japan | ||||
Not provided
Not provided
Not provided
Not provided
|
| Hirosaki |
| Aomori |
| Japan |
| Kashiwa | Chiba | Japan |
| Matsuyama | Ehime | Japan |
| Fukuoka | Fukuoka | Japan |
| Fukuyama | Hiroshima | Japan |
| Hiroshima | Hiroshima | Japan |
| Sapporo | Hokkaido | Japan |
| Amagasaki-shi | Hyōgo | Japan |
| Kobe | Hyōgo | Japan |
| Hitachi | Ibaraki | Japan |
| Takamatsu | Kagawa-ken | Japan |
| Isehara | Kanagawa | Japan |
| Kyoto | Kyoto | Japan |
| Sendai | Miyagi | Japan |
| Nagano | Nagano | Japan |
| Suzaka | Nagano | Japan |
| Nagasaki | Nagasaki | Japan |
| Nara | Nara | Japan |
| Niigata | Niigata | Japan |
| Ōita | Oita Prefecture | Japan |
| Yufu | Oita Prefecture | Japan |
| Kurashiki | Okayama-ken | Japan |
| Okayama | Okayama-ken | Japan |
| Tsuyama | Okayama-ken | Japan |
| Hirakata | Osaka | Japan |
| Osaka | Osaka | Japan |
| Sayama | Osaka | Japan |
| Takatsuki | Osaka | Japan |
| Saga | Saga-ken | Japan |
| Matsue | Shimane | Japan |
| Hamamatsu | Shizuoka | Japan |
| Otawara-shi | Tochigi | Japan |
| Chūō | Tokyo | Japan |
| Minato-ku | Tokyo | Japan |
| Shinagawa-ku | Tokyo | Japan |
| tabashi City | Tokyo | Japan |
| Tottori-shi | Tottori | Japan |
| Toyama | Toyama | Japan |
| Yamagata | Yamagata | Japan |
| Ube | Yamaguchi | Japan |
| Yamaguchi | Yamaguchi | Japan |
| ID | Term |
|---|---|
| D013274 | Stomach Neoplasms |
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D013272 | Stomach Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D064750 | Rabeprazole |
| ID | Term |
|---|---|
| D053799 | 2-Pyridinylmethylsulfinylbenzimidazoles |
| D013454 | Sulfoxides |
| D013457 | Sulfur Compounds |
| D009930 | Organic Chemicals |
| D011725 | Pyridines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D001562 | Benzimidazoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
Not provided
Not provided